Extrahepatic production of acute phase serum amyloid A

Histology and Histopathology

Volumn 20, Issue 4, 2005, Pages 1295-1307

  Upragarin, N ^a,b   Landman, W J M ^c   Gaastra, W ^a   Gruys, E ^a  

^a UTRECHT UNIVERSITY   (Netherlands)

^b KASETSART UNIVERSITY   (Thailand)

^c GD ANIMAL HEALTH   (Netherlands)

Author keywords

AA amyloidosis; Acute phase protein; Extrahepatic production; Isoforms; Serum amyloid A

Indexed keywords

ACUTE PHASE PROTEIN; AMYLOID; PROTEIN PRECURSOR; SERUM AMYLOID A;

AMYLOIDOSIS; BETA SHEET; CHEMOTAXIS; CHICKEN; ELECTRON MICROSCOPY; HUMAN; INFECTION; INFLAMMATION; INJURY; LIPID METABOLISM; LIPID TRANSPORT; MAMMAL; NONHUMAN; PROTEIN BLOOD LEVEL; PROTEIN CONFORMATION; PROTEIN FUNCTION; PROTEIN SYNTHESIS; REVIEW;

ACUTE-PHASE REACTION; AMYLOIDOSIS; ANIMALS; HEPATOCYTES; HUMANS; ORGAN SPECIFICITY; SERUM AMYLOID A PROTEIN;

ANIMALIA; MAMMALIA;

EID: 27144498164     PISSN: 02133911     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (122)

1. Agha I., Mahoney R., Beardslee M., Liapis H., Cowart R.G. and Juknevicius I. (2002). Systemic amyloidosis associated with pleomorphic sarcoma of the spleen and remission of nephrotic syndrome after removal of the tumor. Am. J. Kidney. Dis. 40, 411-415.
2. Ali-Khan Z., Li W. and Chan S.L. (1996). Animal model for the pathogenesis of reactive amyloidosis. Parasitol. Today 12, 297-302.
3. Alizadeh-Khiavi K., Li W., Chronopoulos S. and Ali-Khan Z. (1994). Ubiquitin profile in inflammatory leukocytes and binding of ubiquitin to murine AA amyloid: immunocytochemical and immunogold electron microscopic studies. J. Pathol. 172, 209-217.
4. Alizadeh-Khiavi K., Normand J., Chronopoulos S., Ali A. and Ali-Khan Z. (1992). Amyloid enhancing factor activity is associated with ubiquitin. Virchows Arch. (A) 420, 139-148.
5. Alsemgeest S.P., Horadagoda A., Hulskamp-Koch C.K., Tooten P.C., Kim D.H., Niewold T.A. and Gruys E. (1995). First evidence for the existence of multiple isoforms of bovine serum amyloid-A (apoSAA). Scand. J. Immunol. 41, 407-413.
6. Axelrad M.A., Kisilevsky R., Willmer J., Chen S.J. and Skinner M. (1982). Further characterization of amyloid-enhancing factor. Lab. Invest. 47, 139-146.
7. Baba S., Takahashi T., Kasama T. and Shirasawa H. (1992). Identification of two novel amyloid A protein subsets coexisting in an individual patient of AA-amyloidosis. Biochim. Biophys. Acta 1180, 195-200.
8. Badolato R., Wang J.M., Murphy W.J., Lloyd A.R., Michiel D.F., Bausserman L.L., Kelvin D.J. and Oppenheim J.J. (1994). Serum amyloid A is a chemoattractant: induction of migration, adhesion, and tissue infiltration of monocytes and polymorphonuclear leukocytes. J. Exp. Med. 180, 203-209.
9. Badolato R., Wang J.M., Stornello S.L., Ponzi A.N., Duse M. and Musso T. (2000). Serum amyloid A is an activator of PMN antimicrobial functions: induction of degranulation, phagocytosis, and enhancement of anti-Candida activity. J. Leukoc. Biol. 67, 381-386.
10. Beach C.M., De Beer M.C., Sipe J.D., Loose L.D. and De Beer F.C. (1992). Human serum amyloid A protein. Complete amino acid sequence of a new variant. Biochem. J. 282 (Pt 2), 615-620.
11. Benditt E.P. and Eriksen N. (1977). Amyloid protein SAA is associated with high density lipoprotein from human serum. Proc. Natl. Acad. Sci. USA 74, 4025-4028.
12. Benditt E.P. and Meek R.L. (1989). Expression of the third member of the serum amyloid A gene family in mouse adipocytes. J. Exp. Med. 169, 1841-1846.
13. Betts J.C., Edbrooke M.R., Thakker R.V. and Woo P. (1991). The human acute-phase serum amyloid A gene family: structure, evolution and expression in hepatoma cells. Scand. J. Immunol. 34, 471-482.
14. Brinckerhoff C.E., Mitchell T.I., Karmilowicz M.J., Kluve-Beckerman B. and Benson M.D. (1989). Autocrine induction of collagenase by serum amyloid A-like and beta 2-microglobulin-like proteins. Science 243, 655-657.
15. Cai L., de Beer M.C., de Beer F.C. and van der Westhuyzen D.R. (2005). Serum amyloid a is a ligand for scavenger receptor class B type I and inhibits high density lipoprotein binding and selective lipid uptake. J. Biol. Chem. 280, 2954-2961.
16. Castell J.V., Gomez-Lechon M.J., David M., Hirano T., Kishimoto T. and Heinrich P.C. (1988). Recombinant human interleukin-6 (IL-6/BSF-2/HSF) regulates the synthesis of acute phase proteins in human hepatocytes. FEBS Lett. 232, 347-350.
17. Cathcart E.S., Carreras I., Elliott-Bryant R., Liang J.S., Gonnerman W.A. and Sipe J.D. (1996). Polymorphism of acute-phase serum amyloid A isoforms and amyloid resistance in wild-type Mus musculus czech. Clin. Immunol. Immunopathol. 81, 22-26.
18. Chronopoulos S., Lembo P., Alizadeh-Khiavi K. and Ali-Khan Z. (1992). Ubiquitin: its potential significance in murine AA amyloidogenesis. J. Pathol. 167, 249-259.
19. Chung T.F., Sipe J.D., McKee A., Fine R.E., Schreiber B.M., Liang J.S. and Johnson R.J. (2000). Serum amyloid A in Alzheimer's disease brain is predominantly localized to myelin sheaths and axonal membrane. Amyloid 7, 105-110.
20. Coetzee G.A., Strachan A.F., van der Westhuyzen D.R., Hoppe H.C., Jeenah M.S. and de Beer F.C. (1986). Serum amyloid A-containing human high density lipoprotein 3. Density, size, and apolipoprotein composition. J. Biol. Chem. 261, 9644-9651.
21. de Beer M.C., Beach C.M., Shedlofsky S.I. and de Beer F.C. (1991). Identification of a novel serum amyloid A protein in BALB/c mice. Biochem. J. 280 (Pt 1), 45-49.
22. de Beer M.C., de Beer F.C., Beach C.M., Carreras I. and Sipe J.D. (1992). Mouse serum amyloid A protein. Complete amino acid sequence and mRNA analysis of a new isoform. Biochem. J. 283 (Pt 3), 673-678.
23. de Beer M.C., de Beer F.C., McCubbin W.D., Kay C.M. and Kindy M.S. (1993a). Structural prerequisites for serum amyloid A fibril formation. J. Biol. Chem. 268, 20606-20612.
24. de Beer M.C., de Beer F.C., Beach C.M., Gonnerman W.A., Carreras I. and Sipe J.D. (1993b). Syrian and Armenian hamsters differ in serum amyloid A gene expression. Identification of novel Syrian hamster serum amyloid A subtypes. J. Immunol. 150, 5361-5370.
25. de Beer M.C., Kindy M.S., Lane W.S. and de Beer F.C. (1994). Mouse serum amyloid A protein (SAA5) structure and expression. J. Biol. Chem. 269, 4661-4667.
26. Dwulet F.E., Wallace D.K. and Benson M.D. (1988). Amino acid structures of multiple forms of amyloid-related serum protein SAA from a single individual. Biochemistry 27, 1677-1682.
27. Eanes E.D. and Glenner G.G. (1968). X-ray diffraction studies on amyloid filaments. J. Histochem. Cytochem. 16, 673-677.
28. Fievet P., Sevestre H., Boudjelal M., Noel L.H., Kemeny F., Franco D., Delamarre J. and Capron J.P. (1990). Systemic AA amyloidosis induced by liver cell adenoma. Gut 31, 361-363.
29. Foyn Bruun C., Rygg M., Nordstoga K., Sletten K. and Marhaug G. (1994). Serum amyloid A protein in mink during endotoxin induced inflammation and amyloidogenesis. Scand. J. Immunol. 40, 337-344.
30. Foyn Bruun C., Sletten K. and Marhaug G. (1998). Mouse serum amyloid A (SAA) proteins isolated by two-dimensional electrophoresis: characterization of isotypes and the effect of separate and combined administrations of cytokines, dexamethasone and lipopolysaccharide (LPS) on serum levels and isotype distribution. Clin. Exp. Immunol. 111, 231-236.
31. Friedman E., Farfel Z., Goldfarb D. and Gafni J. (1989). Renal tubular acidosis after prolonged remission of nephrotic syndrome in amyloidosis associated with astrocytoma. South. Med. J. 82, 765-768.
32. Ganapathi M.K., Rzewnicki D., Samols D., Jiang S.L. and Kushner I. (1991). Effect of combinations of cytokines and hormones on synthesis of serum amyloid A and C-reactive protein in Hep 3B cells. J. Immunol. 147, 1261-1265.
33. Gervais C. and Suh M. (1990). Serum amylold A protein-related mRNA expression in herpes simplex virus type 2-transformed hamster cells. Mol. Cell. Biol. 10, 4412-4414.
34. Guo J.T., Aldrich C.E., Mason W.S. and Pugh J.C. (1996). Characterization of serum amyloid A protein mRNA expression and secondary amyloidosis in the domestic duck. Proc. Natl. Acad. Sci. USA. 93, 14548-14553.
35. Guo J.T., Yu J., Grass D., de Beer F.C. and Kindy M.S. (2002). Inflammation-dependent cerebral deposition of serum amyloid a protein in a mouse model of amyloidosis. J. Neurosci. 22, 5900-5909.
36. Hardardottir I., Sipe J., Moser A.H., Fielding C.J., Feingold K.R. and Grunfeld C. (1997). LPS and cytokines regulate extra hepatic mRNA levels of apolipoproteins during the acute phase response in Syrian hamsters. Biochim. Biophys. Acta 1344, 210-220.
37. Hatanaka E., Carvalho B.T., Condino-Neto A. and Campa A. (2004). Hyperresponsiveness of neutrophils from gp 91(phox) deficient patients to lipopolysaccharide and serum amyloid A. Immunol. Lett. 94, 43-46.
38. Hawkins P.N., Richardson S., Vigushin D.M., David J., Kelsey C.R., Gray R.E., Hall M.A., Woo P., Lavender J.P. and Pepys M.B. (1993). Serum amyloid P component scintigraphy and turnover studies for diagnosis and quantitative monitoring of AA amyloidosis in juvenile rheumatoid arthritis. Arthritis Rheum. 36, 842-851.
39. Hershkoviz R., Preciado-Patt L., Lider O., Fridkin M., Dastych J., Metcalfe D.D. and Mekori Y.A. (1997a). Extracellular matrix-anchored serum amyloid A preferentially induces mast cell adhesion. Am. J. Physiol. 273, C179-187.
40. Hershkoviz R., Preciado-Patt L., Lider O., Fridkin M. and Mekori Y.A. (1997b). Mast cell adhesion to extracellular matrix: local effects of acute phase reactants. Int. Arch. Allergy Immunol. 113, 295-296.
41. Hoffman J.S., Ericsson L.H., Eriksen N., Walsh K.A. and Benditt E.P. (1984). Murine tissue amyloid protein AA. NH2-terminal sequence identity with only one of two serum amyloid protein (ApoSAA) gene products. J. Exp. Med. 159, 641-646.
42. Hulten C., Sletten K., Foyn Bruun C. and Marhaug G. (1997). The acute phase serum amyloid A protein (SAA) in the horse: isolation and characterization of three isoforms. Vet. Immunol. Immunopathol. 57, 215-227.
43. Husby G., Marhaug G., Downton B., Sletten K. and Sipe J.D. (1994). Biochemistry, genetics, and the pathogenesis of AA amyloidosis. Amyloid 1, 119-137.
44. Inoue S. and Kisilevsky R. (1999). In situ electron microscopy of amyloid deposits in tissues. Methods Enzymol. 309, 496-509.
45. Kisilevsky R., Lemieux L., Boudreau L., Yang D.S. and Fraser P. (1999). New clothes for amyloid enhancing factor (AEF): silk as AEF. Amyloid 6, 98-106.
46. Kisilevsky R. and Subrahmanyan L. (1992). Serum amyloid A changes high density lipoprotein's cellular affinity. A clue to serum amyloid A's principal function. Lab. Invest. 66, 778-785.
47. Kluve-Beckerman B., Drumm M.L. and Benson M.D. (1991). Nonexpression of the human serum amyloid A three (SAA3) gene. DNA Cell Biol. 10, 651-661.
48. Kovacs B.M., Szilagyi L., Janan J., Toussaint M.J.M., Gruys E. and Rudas P. (2005). Serum amyloid A in goose. In: Proceedings of the fifth international colloquium on animal acute phase proteins, Dublin. p 84.
49. Krishnan J., Chu W.S., Elrod J.P. and Frizzera G. (1993). Tumoral presentation of amyloidosis (amyloidomas) in soft tissues. A report of 14 cases. Am. J. Clin. Pathol. 100, 135-144.
50. Kumon Y., Hosokawa T., Suehiro T., Ikeda Y., Sipe J.D. and Hashimoto K. (2002). Acute-phase, but not constitutive serum amyloid A (SAA) is chemotactic for cultured human aortic smooth muscle cells. Amyloid 9, 237-241.
51. Kumon Y., Sipe J.D., Brinckerhoff C.E. and Schreiber B.M. (1997). Regulation of extrahepatic apolipoprotein serum amyloid A (ApoSAA) gene expression by interleukin-1 alpha alone: synthesis and secretion of ApoSAA by cultured aortic smooth muscle cells. Scand. J. Immunol. 46, 284-291.
52. Kumon Y., Suehiro T., Hashimoto K., Nakatani K. and Sipe J.D. (1999). Local expression of acute phase serum amyloid A mRNA in rheumatoid arthritis synovial tissue and cells. J. Rheumatol. 26, 785-790.
53. Kumon Y., Suehiro T., Hashimoto K. and Sipe J.D. (2001). Dexamethasone, but not IL-1 alone, upregulates acute-phase serum amyloid A gene expression and production by cultured human aortic smooth muscle cells. Scand. J. Immunol. 53, 7-12.
54. Landman W.J., vd Bogaard A.E., Doornenbal P., Tooten P.C., Elbers A.R. and Gruys E. (1998). The role of various agents in chicken amyloid arthropathy. Amyloid 5, 266-278.
55. Larson M.A., Wei S.H., Weber A., Mack D.R. and McDonald T.L. (2003a). Human serum amyloid A3 peptide enhances intestinal MUC3 expression and inhibits EPEC adherence. Biochem. Biophys. Res. Commun. 300, 531-540.
56. Larson M.A., Wei S.H., Weber A., Weber A.T. and McDonald T.L. (2003b). Induction of human mammary-associated serum amyloid A3 expression by prolactin or lipopolysaccharide. Biochem. Biophys. Res. Commun. 301, 1030-1037.
57. Liang J.S., Schreiber B.M., Salmona M., Phillip G., Gonnerman W.A., de Beer F.C. and Sipe J.D. (1996). Amino terminal region of acute phase, but not constitutive, serum amyloid A (apoSAA) specifically binds and transports cholesterol into aortic smooth muscle and HepG2 cells. J. Lipid Res. 37, 2109-2116.
58. Liang J.S. and Sipe J.D. (1995). Recombinant human serum amyloid A (apoSAAp) binds cholesterol and modulates cholesterol flux. J. Lipid Res. 36, 37-46.
59. Liang J.S., Sloane J.A., Wells J.M., Abraham C.R., Fine R.E. and Sipe J.D. (1997). Evidence for local production of acute phase response apolipoprotein serum amyloid A in Alzheimer's disease brain. Neurosci. Lett. 225, 73-76.
60. Lowell C.A., Potter D.A., Stearman R.S. and Morrow J.F. (1986). Structure of the murine serum amyloid A gene family. Gene conversion. J. Biol. Chem. 261, 8442-8452.
61. Lundmark K., Westermark G.T., Nystrom S., Murphy C.L., Solomon A. and Westermark P. (2002). Transmissibility of systemic amyloidosis by a prion-like mechanism. Proc. Natl. Acad. Sci. USA 99, 6979-6984.
62. Mack D.R., McDonald T.L., Larson M.A., Wei S. and Weber A. (2003). The conserved TFLK motif of mammary-associated serum amyloid A3 is responsible for up-regulation of intestinal MUC3 mucin expression in vitro. Pediatr. Res. 53, 137-142.
63. Magy N., Liepnieks J.J., Benson M.D. and Kluve-Beckerman B. (2003). Amyloid-enhancing factor mediates amyloid formation on fibroblasts via a nidus/template mechanism. Arthritis Rheum. 48, 1430-1437.
64. Marhaug G., Hackett B. and Dowton S.B. (1997). Serum amyloid A gene expression in rabbit, mink and mouse. Clin. Exp. Immunol. 107, 425-434.
65. McDonald T.L., Larson M.A., Mack D.R. and Weber A. (2001). Elevated extrahepatic expression and secretion of mammary-associated serum amyloid A 3 (M-SAA3) into colostrum. Vet. Immunol. Immunopathol. 83, 203-211.
66. Meek R.L. and Benditt E.P. (1986). Amyloid A gene family expression in different mouse tissues. J. Exp. Med. 164, 2006-2017.
67. Meek R.L., Eriksen N. and Benditt E.P. (1989). Serum amyloid A in the mouse. Sites of uptake and mRNA expression. Am. J. Pathol. 135, 411-419.
68. Meek R.L., Eriksen N. and Benditt E.P. (1992). Murine serum amyloid A3 is a high density apolipoprotein and is secreted by macrophages. Proc. Natl. Acad. Sci. USA 89, 7949-7952.
69. Meek R.L., Urieli-Shoval S. and Benditt E.P. (1994). Expression of apolipoprotein serum amyloid A mRNA in human atherosclerotic lesions and cultured vascular cells: implications for serum amyloid A function. Proc. Natl. Acad. Sci. USA 91, 3186-3190.
70. Migita K., Kawabe Y., Tominaga M., Origuchi T., Aoyagi T. and Eguchi K. (1998). Serum amyloid A protein induces production of matrix metalloproteinases by human synovial fibroblasts. Lab. Invest. 78, 535-539.
71. Mitchell T.I., Coon C.I. and Brinckerhoff C.E. (1991). Serum amyloid A (SAA3) produced by rabbit synovial fibroblasts treated with phorbol esters or interleukin 1 induces synthesis of collagenase and is neutralized with specific antiserum. J. Clin. Invest. 87, 1177-1185.
72. O'Hara R., Murphy E.P., Whitehead A.S., FitzGerald O. and Bresnihan B. (2000). Acute-phase serum amyloid A production by rheumatoid arthritis synovial tissue. Arthritis Res. 2, 142-144.
73. Olsson N., Siegbahn A. and Nilsson G. (1999). Serum amyloid A induces chemotaxis of human mast cells by activating a pertussis toxin-sensitive signal transduction pathway. Biochem. Biophys. Res. Commun. 254, 143-146.
74. Ordi J., Grau J.M., Junque A., Nomdedeu B., Palacin A. and Cardesa A. (1993). Secondary (AA) amyloidosis associated with Castleman's disease. Report of two cases and review of the literature. Am. J. Clin. Pathol. 100, 394-397.
75. Ovelgönne J.H., Landman W.J., Gruys E., Gielkens A.L. and Peeters B.P. (2001). Identical amyloid precursor proteins in two breeds of chickens which differ in susceptibility to develop amyloid arthropathy. Amyloid 8, 41-51.
76. Patel H., Fellowes R., Coade S. and Woo P. (1998). Human serum amyloid A has cytokine-like properties. Scand. J. Immunol. 48, 410-418.
77. Pepys M.B., Booth D.R., Hutchinson W.L., Gallimore J.R., Collins P.M. and Hohenester E. (1997). Amyloid P component. A critical review. Amyloid 4, 274-295.
78. Preciado-Patt L., Cahalon L., Hershkoviz R., Lider O., Pras M. and Fridkin M. (1998). Serum amyloid A complexed with extracellular matrix induces the secretion of tumor necrosis factor-α by human T-lymphocytes. Lett. Pept. Sci. 5, 349-355.
79. Ramadori G., Sipe J.D. and Colten H.R. (1985). Expression and regulation of the murine serum amyloid A (SAA) gene in extrahepatic sites. J. Immunol. 135, 3645-3647.
80. Ray B.K. and Ray A. (1991). Rabbit serum amyloid a gene: cloning, characterization and sequence analysis. Biochem. Biophys. Res. Commun. 180, 1258-1264.
81. Ray B. K. and Ray A. (1997a). Induction of serum amyloid A (SAA) gene by SAA-activating sequence-binding factor (SAF) in monocyte/macrophage cells. Evidence for a functional synergy between SAF and Sp1. J. Biol. Chem. 272, 28948-28953.
82. Ray B.K. and Ray A. (1997b). Involvement of an SAF-like transcription factor in the activation of serum amyloid A gene in monocyte/macrophage cells by lipopolysaccharide. Biochemistry 36, 4662-4668.
83. Raynes J.G. and McAdam K.P. (1991). Serum amyloid A isoforms in inflammation. Scand. J. Immunol. 33, 657-666.
84. Ribeiro F.P., Furlaneto C.J., Hatanaka E., Ribeiro W.B., Souza G.M., Cassatella M.A. and Campa A. (2003). mRNA expression and release of interleukin-8 induced by serum amyloid A in neutrophils and monocytes. Mediators Inflamm. 12, 173-178.
85. Rokita H., Shirahama T., Cohen A.S., Meek R.L., Benditt E.P. and Sipe J.D. (1987). Differential expression of the amyloid SAA 3 gene in liver and peritoneal macrophages of mice undergoing dissimilar inflammatory episodes. J. Immunol. 139, 3849-3853.
86. Rygg M., Husby G. and Marhaug G. (1993). Differential expression of rabbit serum amyloid A genes in response to various inflammatory agents. Scand. J. Immunol. 38, 417-422.
87. Sack G.H., Jr. and Talbot C.C. Jr (1989). The human serum amyloid A (SAA)-encoding gene GSAA1: nucleotide sequence and possible autocrine-collagenase-inducer function. Gene 84, 509-515.
88. Schreiber B.M., Veverbrants M., Fine R.E., Blusztajn J.K., Salmona M., Patel A. and Sipe J.D. (1999). Apolipoprotein serum amyloid A down-regulates smooth-muscle cell lipid biosynthesis. Biochem. J. 344 Pt 1, 7-13.
89. Sellar G.C., DeBeer M.C., Lelias J.M., Snyder P.W., Glickman L.T., Felsburg P.J. and Whitehead A.S. (1991). Dog serum amyloid A protein. Identification of multiple isoforms defined by cDNA and protein analyses. J. Biol. Chem. 266, 3505-3510.
90. Shephard E.G., de Beer F.C., de Beer M.C., Jeenah M.S., Coetzee G.A. and van der Westhuyzen D.R. (1987). Neutrophil association and degradation of normal and acute-phase high-density lipoprotein 3. Biochem. J. 248, 919-926.
91. Shirahama T., Miura K., Ju S.T., Kisilevsky R., Gruys E. and Cohen A.S. (1990). Amyloid enhancing factor-loaded macrophages in amyloid fibril formation. Lab. Invest. 62, 61-68.
92. Sipe J.D., Araki S., Benson M.D., Cohen A.S., Frangione B., Masters C.L., Saraiva M.J. and Westermark P. (1999). Revised nomenclature for serum amyloid A (SAA). Nomenclature Committee of the International Society of Amyloidosis. Part 2. Amyloid 6, 67-70.
93. Sipe J.D., McAdam K.P. and Uchino F. (1978). Biochemical evidence for the biphasic development of experimental amyloidosis. Lab. Invest. 38, 110-114.
94. Sletten K., Husebekk A. and Husby G. (1989). The primary structure of equine serum amyloid A (SAA) protein. Scand. J. Immunol. 30, 117-122.
95. Sohar E., Gafni J., Pras M. and Heller H. (1967). Familial Mediterranean fever. A survey of 470 cases and review of the literature. Am. J. Med. 43, 227-253.
96. Son D.S., Roby K.F. and Terranova P.F. (2004). Tumor necrosis factor-alpha induces serum amyloid A3 in mouse granulosa cells. Endocrinology 145, 2245-2252.
97. Steel D.M., Donoghue F.C., O'Neill R.M., Uhlar C.M. and Whitehead A.S. (1996). Expression and regulation of constitutive and acute phase serum amyloid A mRNAs in hepatic and non-hepatic cell lines. Scand. J. Immunol. 44, 493-500.
98. Steel D.M., Sellar G.C., Uhlar C.M., Simon S., DeBeer F.C. and Whitehead A.S. (1993). A constitutively expressed serum amyloid A protein gene (SAA4) is closely linked to, and shares structural similarities with, an acute-phase serum amyloid A protein gene (SAA2). Genomics 16, 447-454.
99. Steinmetz A., Hocke G., Saile R., Puchois P. and Fruchart J.C. (1989). Influence of serum amyloid A on cholesterol esterification in human plasma. Biochim. Biophys. Acta 1006, 173-178.
100. Stepanets V., Vernerová Z., Vilhelmová M., Geryk J., Hejnar J. and Svoboda J. (2005). Amyloid A amyloidosis in non-infected and avian leukosis virus-C persistently infected inbred ducks. Avian Pathol. 30, 33-42.
101. Strachan A.F., Brandt W.F., Woo P., van der Westhuyzen D.R., Coetzee G.A., de Beer M.C., Shephard E.G. and de Beer F.C. (1989). Human serum amyloid A protein. The assignment of the six major isoforms to three published gene sequences and evidence for two genetic loci. J. Biol. Chem. 264, 18368-18373.
102. Strachan A.F., de Beer F.C., van der Westhuyzen D.R. and Coetzee G.A. (1988). Identification of three isoform patterns of human serum amyloid A protein. Biochem. J. 250, 203-207.
103. Strissel K.J., Girard M.T., West-Mays J.A., Rinehart W.B., Cook J.R., Brinckerhoff C.E. and Fini M.E. (1997). Role of serum amyloid A as an intermediate in the IL-1 and PMA-stimulated signaling pathways regulating expression of rabbit fibroblast collagenase. Exp. Cell Res. 237, 275-287.
104. Syversen P.V., Saeter U., Cunha-Ribeiro L., Orvim U., Sletten K., Husby G. and Sakariassen K.S. (1994). The effect of serum amyloid protein A fragment-SAA25-76 on blood platelet aggregation. Thromb. Res. 76, 299-305.
105. Syversen P.V., Sletten K., Marhaug G., Husby G. and Lium B. (1993). The revised amino acid sequence of serum amyloid A (SAA) protein in mink. Scand. J. Immunol. 37, 696-697.
106. Teilum G. (1964). The two phase cellular theory of local secretion. Acta Pathol. Microbiol. Immunol. Scand. 61, 21-45.
107. Thysell H., Ingvar C., Gustafson T. and Holmin T. (1986). Systemic reactive amyloidosis caused by hepatocellular adenoma. A case report. J. Hepatol. 2, 450-457.
108. Togashi S., Lim S.K., Kawano H., Ito S., Ishihara T., Okada Y., Nakano S., Kinoshita T., Horie K., Episkopou V., Gottesman M.E., Costantini F., Shimada K. and Maeda S. (1997). Serum amyloid P component enhances induction of murine amyloidosis. Lab. Invest. 77, 525-531.
109. Upragarin N., Landman W.J., van Asten A.J.A.M., Toussaint M.J.M., van Ederen A.M. and Gruys E. (2002). Serum amyloid A (SAA) mRNA and protein expression in primary culture chicken synoviocytes. In: Proceedings of the third European colloquium on food safety and acute phase proteins, Utrecht. p 72.
110. Urieli-Shoval S., Cohen P., Eisenberg S. and Matzner Y. (1998). Widespread expression of serum amyloid A in histologically normal human tissues. Predominant localization to the epithelium. J. Histochem. Cytochem. 46, 1377-1384.
111. Urieli-Shoval S., Meek R.L., Hanson R.H., Eriksen N. and Benditt E.P. (1994). Human serum amyloid A genes are expressed in monocyte/macrophage cell lines. Am. J. Pathol. 145, 650-660.
112. Usui I., Kawano H., Ito S., Hamada Y., Ishihara T. and Maeda S. (2001). Homozygous serum amyloid P component-deficiency does not enhance regression of AA amyloid deposits. Amyloid 8, 101-104.
113. Vallon R., Freuler F., Desta-Tsedu N., Robeva A., Dawson J., Wenner P., Engelhardt P., Boes L., Schnyder J., Tschopp C., Urfer R. and Baumann G. (2001). Serum amyloid A (apoSAA) expression is upregulated in rheumatoid arthritis and induces transcription of matrix metalloproteinases. J. Immunol. 166, 2801-2807.
114. Vreugdenhil A.C., Dentener M.A., Snoek A.M., Greve J.W. and Buurman W.A. (1999). Lipopolysaccharide binding protein and serum amyloid A secretion by human intestinal epithelial cells during the acute phase response. J. Immunol. 163, 2792-2798.
115. Webb C.F., Tucker P.W. and Dowton S.B. (1989). Expression and sequence analyses of serum amyloid A in the Syrian hamster. Biochemistry 28, 4785-4790.
116. Wens R., Goffin Y., Pepys M.B., Kutnowski M., Van Beers D., Decoodt P. and Verbanck M. (1989). Left atrial myxoma associated with systemic AA amyloidosis. Arch. Intern. Med. 149, 453-454.
117. Westermark P., Benson M.D., Buxbaum J.N., Cohen A.S., Frangione B., Ikeda S., Masters C.L., Merlini G., Saraiva M.J. and Sipe J.D. (2002). Amyloid fibril protein nomenclature 2002. Amyloid 9, 197-200.
118. Westermark P., Sletten K., Westermark G.T., Raynes J. and McAdam K.P. (1996). A protein AA-variant derived from a novel serum AA protein, SAA1 delta, in an individual from Papua New Guinea. Biochem. Biophys. Res. Commun. 223, 320-323.
119. Whitehead A.S., de Beer M.C., Steel D.M., Rits M., Lelias J.M., Lane W.S. and de Beer F.C. (1992). Identification of novel members of the serum amyloid A protein superfamily as constitutive apolipoproteins of high density lipoprotein. J. Biol. Chem. 267, 3862-3867.
120. Xu L., Badolato R., Murphy W.J., Longo D.L., Anver M., Hale S., Oppenheim J.J. and Wang J.M. (1995). A novel biologic function of serum amyloid A. Induction of T lymphocyte migration and adhesion. J. Immunol. 155, 1184-1190.
121. Yamada T., Kakihara T., Kamishima T., Fukuda T. and Kawai T. (1996). Both acute phase and constitutive serum amyloid A are present in atherosclerotic lesions. Pathol. Int. 46, 797-800.
122. Zimlichman S., Danon A., Nathan I., Mozes G. and Shainkin-Kestenbaum R. (1990). Serum amyloid A, an acute phase protein, inhibits platelet activation. J. Lab. Clin. Med. 116, 180-186.